Bathi saben saham sajrone rolas wulan pungkasan: XBiotech Inc (XBIT)
The targeted robotization of XBiotech Inc. (XBIT) laboratories may seem modest, yet the fundamental TTM net income per share clearly demonstrates efficiency dynamics, with the indicator standing at -1.49. The expansion of the True Human platform to capture market share resolves any doubts, while the use of natural genes enables the company to establish premium pricing for safe cancer therapy methods.
XBiotech Inc - rincian analitis lan metrik utama (XBIT)
- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi bursa perusahaan:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal XBiotech Inc.|XBIT - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal XBiotech USA|XBIT - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku XBiotech Inc.|XBIT - Utang jangka dawa|Kewajiban jangka cendhak perusahaan XBiotech|Rasio cepet xbiotech.com
- indikator pendapatan resik lan kelipatan nilai:
XBIT - Penghasilan resik perusahaan|Proyeksi bathi mangsa ngarep XBiotech Inc.|XBIT - Koefisien rega marang bathi|Pangali Forward P/E XBiotech USA|XBIT - Koefisien bali modal nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan XBiotech Inc.|XBIT - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) XBiotech|XBIT - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan xbiotech.com|XBIT - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep XBiotech Inc.
Analisis fundamental perusahaan:XBIT - xbiotech.com
Net income per share over 12 months measures the proportional earnings allocated to each share after all expenses are deducted. For XBiotech Inc. (XBIT), this result depends directly on the commercialization of antibodies and the success of clinical trials. By analyzing the TTM earnings per share metric, an investor can discern the actual financial stability of the business. The trend line allows for an assessment of drawdown risks when purchasing the asset. This metric confirms the quality of the company's capitalization.
Pesaing utama
ONC: Bathi resik saben saham sajrone 12 wulan pungkasan|HALO - Bathi resik saben saham (EPS TTM)|Revolution Medicines, Inc. (RVMD) - Bathi saben saham sajrone rolas wulan pungkasan|Ascentage Pharma Group International - Bathi saben saham sajroning taun lumaku|CGON (CG Oncology Corp) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan UroGen Pharma Corp URGN|Bathi resik saben saham sajrone 12 wulan pungkasan BCAX (Bicara Therapeutics Inc.)|personalis.com - Bathi saben saham sajrone 12 wulan pungkasan|Bathi resik saben saham (EPS TTM) ERAS (Erasca)|Delcath Systems Inc - Bathi saben saham sajrone rolas wulan pungkasan|YmAbs - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone patang kuartal pungkasan Aura Corp AURA|candeltx.com (CADL) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi resik saben siji saham sajrone rolas wulan pungkasan accuray.com (ARAY)|Bathi resik saben saham sajrone 12 wulan pungkasan SLS|ACTU (Actuate Therapeutics Inc.) - Bathi saben saham sajrone patang kuartal pungkasan|Bathi resik saben saham (EPS TTM) CTOR|HURA - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Bathi resik saben saham (EPS TTM) TARA (Protara Therapeutics)|FATE - Bathi resik saben saham sajrone 12 wulan pungkasan|Aadi Bio - Bathi resik saben saham (EPS TTM)|Bathi saben saham sajroning taun lumaku TCRX (TScan Therapeutics)|CSBR (championsoncology.com) - Bathi resik saben saham sajrone 12 wulan pungkasan|CEL-SCI - Bathi saben saham sajroning taun lumaku|OSTX (OS Therapies Incorporated) - Bathi resik saben saham (EPS TTM)|radiopharmtheranostics.com (RADX) - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Artiva Biotherapeutics, Inc. (ARTV)|adlainortye.com - Bathi saben saham sajrone 12 wulan pungkasan|Bathi resik saben saham (EPS TTM) VERU (Veru Pharma)|TPST - Bathi resik saben saham sajrone 12 wulan pungkasan|XLO: Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi resik saben saham sajrone patang kuartal pungkasan Renovaro Inc. RENB|MURA (muraloncology.com) - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajrone 12 wulan pungkasan KAPA|OKUR (OnKure Therapeutics, Inc.) - Bathi resik saben saham (EPS TTM)|Bathi saben saham sajrone rolas wulan pungkasan GDTC|Bathi resik saben saham (EPS TTM) CRIS|Bathi resik saben saham sajrone patang kuartal pungkasan apollomicsinc.com|Tharimmune - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajrone patang kuartal pungkasan ADVB (Advanced Biomed Inc.)|Genprex, Inc - Bathi resik saben saham (EPS TTM)|Calidi Biotherapeutics (CLDI) - Bathi resik saben saham sajrone 12 wulan pungkasan|SBFM: Bathi resik saben saham (EPS TTM)|Xenetic Biosciences, Inc. (XBIO) - Bathi resik saben saham (EPS TTM)|Bathi saben saham sajrone rolas wulan pungkasan Salarius Pharmaceuticals, Inc.|Bathi saben saham sajrone 12 wulan pungkasan PPBT (Purple Biotech Ltd)|Bathi resik saben saham (EPS TTM) AONC|Bathi resik saben saham sajrone 12 wulan pungkasan BeiGene Ltd BGNE|Bathi resik saben saham (EPS TTM) CKPT (Checkpoint Therapeutics)|elevationoncology.com (ELEV) - Bathi resik saben siji saham sajrone rolas wulan pungkasan|ICAD - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajroning taun lumaku IKNA (Ikena Oncology, Inc.)|NTBL (Notable Labs Inc.) - Bathi resik saben saham sajrone 12 wulan pungkasan|Viracta Therapeutics, Inc. - Bathi saben saham sajroning taun lumaku|MOR (MorphoSys AG) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone 12 wulan pungkasan nayabiosciences.com (NAYA)|Bathi resik saben saham sajrone 12 wulan pungkasan AAPGV (Ascentage Pharma)
